Endovia Health Sciences closes $500,000 tranche for CannEpil development
Endovia Health Sciences said it closed an initial $500,000 secured convertible debt tranche to advance development and commercialization of CannEpil.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.